US Edition
Published • loading... • Updated
Postmenopausal Weight Loss: Estrogen Could Enhance the Effect of Tirzepatide
Summary by Deutsches Ärzteblatt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Jacksonville/Rochester – In overweight postmenopausal women, the weight-reducing and cardiometabolically protective effects of tirzepatide are greater when these women are receiving hormone replacement therapy. This was the conclusion of a research group at the Mayo Clinic based on a retrospective cohort study (Lancet Obstet Gynaecol Womens...).
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
